PIRISI, Mario
 Distribuzione geografica
Continente #
EU - Europa 11.159
NA - Nord America 9.766
AS - Asia 6.741
SA - Sud America 1.268
AF - Africa 279
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 17
AN - Antartide 1
Totale 29.254
Nazione #
US - Stati Uniti d'America 9.480
IE - Irlanda 2.751
SG - Singapore 2.392
IT - Italia 1.710
DE - Germania 1.556
HK - Hong Kong 1.325
SE - Svezia 1.311
CN - Cina 1.162
BR - Brasile 1.005
UA - Ucraina 936
FR - Francia 776
RU - Federazione Russa 755
VN - Vietnam 606
FI - Finlandia 488
IN - India 433
GB - Regno Unito 291
KR - Corea 231
CA - Canada 185
ID - Indonesia 136
BJ - Benin 134
CZ - Repubblica Ceca 132
AR - Argentina 108
AT - Austria 91
PL - Polonia 91
TR - Turchia 86
MX - Messico 73
ZA - Sudafrica 65
BD - Bangladesh 62
IR - Iran 60
JP - Giappone 60
NL - Olanda 60
ES - Italia 58
BE - Belgio 47
EC - Ecuador 37
CL - Cile 35
LT - Lituania 32
PK - Pakistan 31
IQ - Iraq 26
EG - Egitto 23
CO - Colombia 20
EU - Europa 20
PE - Perù 18
PY - Paraguay 18
VE - Venezuela 16
CH - Svizzera 15
AU - Australia 14
SA - Arabia Saudita 12
IL - Israele 11
KE - Kenya 11
MA - Marocco 11
MY - Malesia 11
NP - Nepal 10
RO - Romania 10
TW - Taiwan 10
NG - Nigeria 9
TN - Tunisia 9
PH - Filippine 8
AE - Emirati Arabi Uniti 7
TH - Thailandia 7
UZ - Uzbekistan 7
AL - Albania 6
DO - Repubblica Dominicana 6
UY - Uruguay 6
BH - Bahrain 5
DZ - Algeria 5
JO - Giordania 5
KZ - Kazakistan 5
PT - Portogallo 5
RS - Serbia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BO - Bolivia 4
JM - Giamaica 4
LK - Sri Lanka 4
MO - Macao, regione amministrativa speciale della Cina 4
OM - Oman 4
BA - Bosnia-Erzegovina 3
GR - Grecia 3
GT - Guatemala 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
CU - Cuba 2
DK - Danimarca 2
GE - Georgia 2
KG - Kirghizistan 2
LB - Libano 2
LI - Liechtenstein 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
PA - Panama 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 29.227
Città #
Dublin 2.732
Jacksonville 1.657
Hong Kong 1.308
Singapore 745
Dearborn 733
Ashburn 642
Chandler 603
Beijing 600
Wilmington 431
Novara 343
Princeton 333
Lawrence 332
Los Angeles 322
Moscow 277
San Mateo 252
Ann Arbor 241
Munich 224
Piemonte 216
Buffalo 203
Seoul 202
Ho Chi Minh City 192
Milan 159
New York 141
Cotonou 134
Andover 130
São Paulo 129
Hanoi 112
Houston 110
Boardman 107
Turin 93
Jakarta 90
Helsinki 86
Dallas 78
Nuremberg 77
Brno 73
Woodbridge 71
Vercelli 70
Frankfurt am Main 68
Warsaw 68
Redondo Beach 66
Bremen 65
Santa Clara 65
Chennai 64
Denver 62
Dong Ket 60
Nanjing 59
London 58
Brooklyn 57
Montreal 57
Poplar 56
Turku 53
Johannesburg 50
Hefei 49
Toronto 49
Stockholm 48
Tokyo 46
Brussels 45
Orem 45
Atlanta 44
Philadelphia 42
Seattle 39
Boston 38
Düsseldorf 37
Phoenix 37
Vienna 37
Falkenstein 36
Pardubice 34
Tianjin 34
Norwalk 33
Ankara 30
Chicago 29
Mexico City 29
Kunming 28
Kocaeli 27
Mumbai 26
Rome 25
Da Nang 24
Rio de Janeiro 24
Amsterdam 23
Torino 23
Hải Dương 21
Monmouth Junction 20
Alessandria 19
Biên Hòa 19
Brasília 19
Curitiba 19
Haiphong 19
Mülheim 19
Querétaro 19
Salvador 19
Assago 18
Augusta 18
Fairfield 18
Jinan 18
Manchester 18
Porto Alegre 18
Guangzhou 17
Nanchang 17
Strasbourg 17
Ardabil 16
Totale 16.505
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 330
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 260
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 207
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 204
Genistein and 17β-Estradiol Protect Hepatocytes from Fatty Degeneration by Mechanisms Involving Mitochondria, Inflammasome and Kinases Activation 174
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 149
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 143
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 138
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 136
Testosterone Plasma Concentration is Associated with Insulin Resistance in Male Hypertensive Patients 136
Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study. 134
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study 134
Change over time of COVID-19 hospital presentation in Northern Italy 132
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 131
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 130
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 130
Role of beta-blockers in patients with COPD: current perspective. 126
Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis 126
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 122
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 121
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 120
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 119
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 119
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 119
Acute decompensated heart failure in the emergency department: Identification of early predictors of outcome 118
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 117
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 116
Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. 115
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside ICU 115
Association between rheumatic diseases and cancer: results from a clinical practice cohort study 113
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 111
Pattern of emergency department referral during the Covid-19 outbreak in Italy 111
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 111
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 110
Is cholecalciferol a potential disease modifying anti-rheumatic drug for the management of rheumatoid arthritis? 110
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib 109
"war to the knife" against thromboinflammation to protect endothelial function of COVID-19 patients 109
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 109
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 109
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 108
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 108
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 107
Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis 106
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 105
Vitamin D in Systemic Sclerosis: A Review 104
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 104
Diagnostic value of FibroTest with normal serum aminotransferases 102
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 102
Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease 101
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 101
Influence of age on sex-related differences among patients with hepatitis C. 101
One-Year Follow up of Noninvasive Respiratory Support in General Wards 100
4. Association between release of tumor necrosis factor and response to interferon therapy in chronic hepatitis C 100
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 100
First reported human case of meningitis by Staphylococcus condimenti 100
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 99
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 99
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 99
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 98
An unusual adverse reaction to iodine-based contrast agent. 98
A woman with anemia and a small bowel obstruction 96
AORTIC INVOLVEMENT IN A RETROSPECTIVE COHORT OF LARGE VESSEL VASCULITIS PATIENTS 96
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 96
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 96
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 95
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 95
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 95
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 94
Profiling the patients visiting the emergency room for musculoskeletal complaints: characteristics and outcomes 94
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival 93
Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice 93
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 93
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 93
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 92
Recent advances in the pathophysiology, diagnosis and treatment of hereditary hemochromatosis and other iron overload syndromes 92
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 92
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 91
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 91
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 90
Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication 90
A case of false positive troponin I in a patient affected by cryoglobulinemic vasculitis 90
Understanding protection from SARS-CoV-2 using metabolomics 90
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 90
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 90
(Letter) Membranoproliferative glomerulonephritis associated with Hepatitis C infection with no evidence of liver disease 89
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 89
Recent advances in HCV entry 89
ACE genotype, body weight changes and target organ damage in renal transplant recipients 89
Prediction of serum markers of fibrosis by levels of circulating intercellular adhesion molecule-1 in acute and chronic liver disease 88
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 88
Impaired glucose metabolism in hypertensive patients with/without the metabolic syndrome. 88
Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis 88
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 88
A 28-Year-Old Woman with Ascites and Multiple Focal Spleen Lesions 88
Eosinophilic gastroenteritis in pregnancy: A review of the literature 88
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 88
Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis 88
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 88
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 87
A rare cause of intractable diarrhea 87
Totale 11.102
Categoria #
all - tutte 169.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.091


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.342 0 0 0 0 0 97 317 50 326 77 363 112
2021/20222.287 101 58 459 228 112 28 168 80 196 104 284 469
2022/20235.491 502 220 276 151 299 444 165 229 2.827 34 223 121
2023/20242.577 140 341 149 76 391 74 482 134 54 86 249 401
2024/20255.263 134 65 261 144 146 336 518 545 1.193 490 390 1.041
2025/20267.004 775 664 1.143 2.452 1.703 267 0 0 0 0 0 0
Totale 29.955